| Literature DB >> 20515494 |
Jun Qu1, Alan J Lesse, Aimee L Brauer, Jin Cao, Steven R Gill, Timothy F Murphy.
Abstract
BACKGROUND: Nontypeable Haemophilus influenzae colonizes and infects the airways of adults with chronic obstructive pulmonary disease, the fourth most common cause of death worldwide.Thus, H. influenzae, an exclusively human pathogen, has adapted to survive in the hostile environment of the human airways.To characterize proteins expressed by H. influenzae in the airways, a prototype strain was grown in pooled human sputum to simulate conditions in the human respiratory tract.The proteins from whole bacterial cell lysates were solubilized with a strong buffer and then quantitatively cleaned with an optimized precipitation/on-pellet enzymatic digestion procedure.Proteomic profiling was accomplished by Nano-flow liquid chromatography/mass spectroscopy with low void volume and high separation efficiency with a shallow, long gradient.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20515494 PMCID: PMC2887450 DOI: 10.1186/1471-2180-10-162
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Chromatogram showing elution gradient for the separation of bacterial lysate by Nano-flow liquid chromatography. X- axis:elution time.Y-axis: Mass spectrometry signal intensity.
Proteins of the glycolysis pathway identified in H. influenzae strain 11P6H identified during growth in pooled human sputum
| Protein ID# | Identified Protein | Gene | Molecular Weight | |||
|---|---|---|---|---|---|---|
| 1237 | phosphoenolpyruvate-protein phosphotransferase | HI0446 | 64 kDa | 100% (9.7%) | 100% (11%) | |
| 412 | Fructose specific phosphotransferase system IIA/HPr components | HI0448 | 53 kDa | 100% (24%) | 100% (8.2%) | |
| 1149 | Aldose 1-epimerase | HI0818 | 38 kDa | 100% (11%) | 100% (15%) | |
| 423 | 1-phosphofructokinase | HI0447 | 34 kDa | 100% (24%) | 100% (15%) | |
| 557 | 6-phosphofructokinase | HI0982 | 23 kDa | 100% (21%) | 95% (20%) | |
| 57 | Fructose-bisphosphate aldolase | HI0524 | 39 kDa | 100% (47%) | 100% (36%) | |
| 657 | glucose-6-phosphate isomerase | HI1576 | 37 kDa | 100% (19%) | 100% (15%) | |
| 392 | Triosephosphate isomerase | HI0678 | 27 kDa | 100% (25%) | 100% (19%) | |
| 97 | Glyceraldehyde-3-phosphate dehydrogenase | HI0001 | 36 kDa | 100% (40%) | 100% (39%) | |
| 111 | 3-phosphoglycerate kinase | HI0525 | 41 kDa | 100% (39%) | 100% (37%) | |
| 34 | phosphoglyceromutase | HI0757 | 26 kDa | 100% (52%) | 100% (56%) | |
| 79 | enolase | HI0932 | 46 kDa | 100% (43%) | 100% (32%) | |
| 133 | Pyruvate kinase | HI1573 | 49 kDa | 100% (37%) | 100% (47%) | |
| 538 | Dihydrolipoamide acetyltransferase | HI1232 | 57 kDa | 100% (22%) | 100% (23%) | |
| 305 | Pyruvate dehydrogenase subunit E1 | HI1233 | 99 kDa | 100% (28%) | 100% (30%) | |
aID numbers based on annotation of H. influenzae strain KW20 Rd http://cmr.jcvi.org/cgi-bin/CMR/GenomePage.cgi?org=ghi
bProtein probabilities values as calculated by Proteinprophet algorithm for proteins detected during growth in chemically define media (CDM). Number in parentheses represents the sequence coverage expressed by the percentage of amino acid residues identified. All peptides were filtered with a set of criteria as specified in the Methods. CDM
cProtein probabilities for proteins detected during growth in 20% pooled human sputum.
Figure 2Distribution of functional categories of 31 proteins that were present in increased abundance during growth of . Distribution of functional categories of 31 proteins that were present in increased abundance during growth of H. influenzae in 20% pooled human sputum compared to growth in chemically defined media. One protein is classified in two categories accounting for the total of 32.
Composition of chemically defined media (CDM)
| Reagent | Concentration |
|---|---|
| NaCl | 0.1 M |
| K2SO4 | 5.75 mM |
| Na2EDTA | 4 mM |
| NH4Cl | 4 mM |
| K2HPO4 | 2 mM |
| KH2PO4 | 2 mM |
| Thiamine HCl | 6 μM |
| Thiamine pyrophosphate | 1 μM |
| Pantothenic acid | 8 μM |
| d-Biotin | 12 μM |
| Glucose | 0.5% |
| Hypoxanthine | 0.375 mM |
| Uracil | 0.45 mM |
| L-aspartic acid | 3.75 mM |
| L-glutamic acid HCl | 7.5 mM |
| L-arginine | 0.875 mM |
| Glycine HCl | 0.225 mM |
| L-serine | 0.475 mM |
| L-leucine | 0.7 mM |
| L-isoleucine | 0.225 mM |
| L-valine | 0.525 mM |
| L-tyrosine | 0.4 mM |
| L-cysteine HCl | 0.35 mM |
| L-cystine | 0.15 mM |
| L-proline | 0.45 mM |
| L-tryptophan | 0.4 mM |
| L-threonine | 0.425 mM |
| L-phenylalanine | 0.15 mM |
| L-asparagine | 0.2 mM |
| L-glutamine | 0.35 mM |
| L-histidine HCl | 0.125 mM |
| L-methionine | 0.1 mM |
| L-alanine | 1.125 mM |
| L-lysine | 0.35 mM |
| Glutathione reduced | 0.15 mM |
| HEPES | 42 mM |
| NaHCO3 | 0.125 mM |
| Na acetate trihydrate | 6.25 mM |
| Choline chloride salt | 0.05 mM |
| Myo-inositol | 1 μM |
| MgCl2 | 2.5 mM |
| CaCl2 | 0.6 mM |
| Fe(NO3)3 | 0.1 mM |
| Nicotinamide adenine dinucleotide | 0.02 mM |
| Protoporphyrin IX | 0.02 mM |
| Histidine | 6 μM |
| Triethanolamine | 0.01% |